Agenda Archive

PANEL DISCUSSION: Turning Transit Troubles into Triumphs: Proven Strategies for Clinical Supply Success

Common causes of transit issues: shipment delays, temperature excursions, customs holds, and packaging failures
Addressing gaps in global regulatory guidance
Practical solutions for streamlining supply chain processes

Understanding the complexities and challenges of the end-to-end pharmaceutical supply chain, from manufacturing to patient delivery
Addressing regulatory requirements and compliance
How did we implement effective strategies to enhance the end-to-end pharmaceutical supply chain

In H1, trial initiations significantly increased in comparison to previous years
Explore the latest trial trends, challenges, and opportunities for suppliers shaping clinical trials this year
See how this has shaken up the biopharma competitive landscape and how this will affect the clinical trial supply chain

This presentation explores how AR1001 is poised to redefine the Alzheimer’s disease (AD) treatment landscape as a first-in-class, oral, disease-modifying therapy — bringing fresh momentum to a field that has seen limited progress over the past two decades
We will delve into the scientific breakthroughs and strategic learnings gained through years of innovation and perseverance within the highly challenging global AD space
Finally, we spotlight AriBio’s commitment to delivering the right therapy to the right patients at the right time, while upholding rigorous global regulatory and quality standards to support successful approvals in both the U.S. (FDA) and Europe (EMA)